直肠癌根治性治疗后的功能结局与健康相关生活质量:英格兰一项人群水平研究
研究基于2013年1月英格兰结直肠癌诊断后12至36个月患者的调查数据,最终分析3998例大切除后缓解的直肠癌患者。术前放疗者报告肠道控制差、严重尿漏和严重性困难的比值比高于单纯手术者;长程放化疗者肠道控制优于短程放疗者;造口者严重性困难和健康相关生活质量更差。
要点
- 术前放疗者较单纯手术者报告肠道控制差(43.6% vs 33.0%;OR=1.55;95%CI 1.26-1.91)。
- 术前放疗者严重尿漏(7.2% vs 3.5%;OR=1.69;95%CI 1.18-2.43)和严重性困难(34.4% vs 18.3%;OR=1.73;95%CI 1.43-2.11)比值比更高。
- 长程放化疗者肠道控制显著优于短程放疗者,其他结局无差异;造口者严重性困难和健康相关生活质量更差。
核心结论
- 研究显示术前放疗患者报告更差的结局,尤其是肠道和性功能,并强调造口的负面影响。
研究设计与样本
- 2013年1月向英格兰所有诊断结直肠癌后12至36个月的患者发送调查问卷,通过国家癌症注册与分析服务链接癌症注册、住院和放疗数据。
主要发现
- 10452例直肠癌患者中6713例(64.2%)返回问卷,其中3998例大切除后缓解者构成最终分析样本。
- 术前放疗者较单纯手术者报告肠道控制差(43.6% vs 33.0%;OR=1.55;95%CI 1.26-1.91)。
- 术前放疗者较单纯手术者报告严重尿漏(7.2% vs 3.5%;OR=1.69;95%CI 1.18-2.43)和严重性困难(34.4% vs 18.3%;OR=1.73;95%CI 1.43-2.11)的比值比更高。
- 长程放化疗者报告肠道控制显著优于短程放疗者,其他结局无差异。
- 当前有造口者报告严重性困难水平显著更高且健康相关生活质量更差,相较于从未造口或造口还纳者。
临床怎么用
- 作者希望其经验能鼓励研究者在其他医疗体系中开展类似研究。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: There is a growing population of cancer survivors at risk of treatment-related morbidity. This study investigated how potentially curative rectal cancer treatment influences subsequent function and health-related quality of life using data from a large-scale survey of patient-reported outcomes. METHODS AND MATERIALS: All individuals 12 to 36 months after receiving a diagnosis of colorectal cancer in England were sent a survey in January 2013. The survey responses were linked with cancer registration, hospital admissions, and radiation therapy data through the National Cancer Registration and Analysis Service. Outcome measures were cancer specific (Functional Assessment of Cancer Therapy and Social Difficulties Inventory items related to fecal incontinence, urinary incontinence, and sexual difficulties) and generic (EuroQol EQ-5D). RESULTS: Surveys were returned by 6713 (64.2%) of 10,452 patients with rectal cancer. Of these, 3998 patients were in remission after a major resection and formed the final analysis sample. Compared with those who had surgery alone, patients who received preoperative radiation therapy had higher odds of reporting poor bowel control (43.6% vs 33.0%; odds ratio [OR] = 1.55; 95% confidence interval [CI], 1.26-1.91), severe urinary leakage (7.2% vs 3.5%; OR = 1.69; 95% CI, 1.18-2.43), and severe sexual difficulties (34.4% vs 18.3%; OR = 1.73; 95% CI, 1.43-2.11). Patients who received long-course chemoradiotherapy reported significantly better bowel control than those who had short-course radiation therapy, with no difference for other outcomes. Respondents with a stoma present reported significantly higher levels of severe sexual difficulties and worse health-related quality of life than those who had never had a stoma or had undergone stoma reversal. CONCLUSIONS: This study demonstrated the feasibility of a large-scale assessment of patient-reported outcomes and provided "real-world" data regarding the effect of rectal cancer treatment. The results show that patients who receive preoperative radiation therapy reported poorer outcomes, particularly for bowel and sexual function, and highlighted the negative impact of a stoma. We hope that our experience will encourage researchers to perform similar studies in other healthcare systems.
引用
- Downing A, Glaser AW, Finan PJ, et al. Functional Outcomes and Health-Related Quality of Life After Curative Treatment for Rectal Cancer: A Population-Level Study in England. Int J Radiat Oncol Biol Phys. 2018. PMID: 30553942. doi:10.1016/j.ijrobp.2018.12.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。